Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務情報

◆英語タイトル:Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13401
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Goldman Sachs Private Wealth Management – Strategy, SWOT and Corporate Finance Report
Summary

Goldman Sachs Private Wealth Management – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Goldman Sachs Private Wealth Management (Goldman Sachs PWM) is a private wealth management division of Goldman Sachs that offers a wide range of private banking and wealth administration solutions. Its offerings include investment advisory; trading, hedging, and structuring solutions; wealth advisory; and private banking and lending. It also offers trust and estate management, banking solutions, and institutional wealth management. The bank operates through a network of its branch offices, online portals, and wealth managers and serves to high-net-worth individuals, families, and institutional clients. It operates in the Americas, Europe, Middle-East, and Asia-Pacific regions. Goldman Sachs PWM is headquartered in New York City, New York, the US.

Scope

- Detailed information on Goldman Sachs Private Wealth Management required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Goldman Sachs Private Wealth Management in the form of a SWOT analysis
- An in-depth view of the business model of Goldman Sachs Private Wealth Management including a breakdown and examination of key business segments
- Intelligence on Goldman Sachs Private Wealth Management’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Goldman Sachs Private Wealth Management, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Goldman Sachs Private Wealth Management and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Goldman Sachs Private Wealth Management as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Goldman Sachs Private Wealth Management’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Goldman Sachs Private Wealth Management: Company Overview
Goldman Sachs Private Wealth Management: Overview and Key Facts
Goldman Sachs Private Wealth Management: Overview
Goldman Sachs Private Wealth Management: Key Facts
Goldman Sachs Private Wealth Management: Key Employees
Goldman Sachs Private Wealth Management: Major Products and Services
Goldman Sachs Private Wealth Management: Company History
Goldman Sachs Private Wealth Management: Locations and Subsidiaries
Goldman Sachs Private Wealth Management: Key Competitors
Goldman Sachs Private Wealth Management: Company Analysis
Goldman Sachs Private Wealth Management: Business Description
Goldman Sachs Private Wealth Management: SWOT Analysis
Goldman Sachs Private Wealth Management: SWOT Overview
Goldman Sachs Private Wealth Management: Strengths
Goldman Sachs Private Wealth Management: Weaknesses
Goldman Sachs Private Wealth Management: Opportunities
Goldman Sachs Private Wealth Management: Threats
Goldman Sachs Private Wealth Management: Corporate Financial Deals Activity
Goldman Sachs Private Wealth Management: Financial Deals Overview
Goldman Sachs Private Wealth Management: Targets and Partners
Goldman Sachs Private Wealth Management: Top Deals 2015 – 2019YTD*
Goldman Sachs Private Wealth Management: Mergers and Acquisitions
Goldman Sachs Private Wealth Management: Corporate Venturing
Goldman Sachs Private Wealth Management: Recent Developments
Goldman Sachs Private Wealth Management: News and Events Summary
Goldman Sachs Private Wealth Management: Business Expansion
Goldman Sachs Private Wealth Management: Contracts
Goldman Sachs Private Wealth Management: Corporate Governance
Goldman Sachs Private Wealth Management: Financial Deals
Goldman Sachs Private Wealth Management: Financial Performance
Goldman Sachs Private Wealth Management: Regulatory and Legal Events
Goldman Sachs Private Wealth Management: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Goldman Sachs Private Wealth Management: Key Facts
Table 2: Goldman Sachs Private Wealth Management: Key Employees
Table 3: Goldman Sachs Private Wealth Management: Company History
Table 4: Goldman Sachs Private Wealth Management: Locations and Subsidiaries
Table 5: Goldman Sachs Private Wealth Management: Key Competitors
Table 6: Goldman Sachs Private Wealth Management: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Goldman Sachs Private Wealth Management: M&A Activity by Geography (TTM*)
Table 8: Goldman Sachs Private Wealth Management: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: Goldman Sachs Private Wealth Management: M&A Average Deal Size - Value (US$m)
Table 10: Goldman Sachs Private Wealth Management: Targets and Partners
Table 11: Goldman Sachs Private Wealth Management: Top Deals 2015 - 2019YTD*
Table 12: Goldman Sachs Private Wealth Management: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: Goldman Sachs Private Wealth Management: M&A Activity by Geography (2015 - YTD*2019)
Table 14: Goldman Sachs Private Wealth Management: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 15: Goldman Sachs Private Wealth Management: Corporate Venturing by Geography (2015 - YTD*2019)
Table 16: Goldman Sachs Private Wealth Management: News and Events Summary
Table 17: Goldman Sachs Private Wealth Management: Business Expansion
Table 18: Goldman Sachs Private Wealth Management: Contracts
Table 19: Goldman Sachs Private Wealth Management: Corporate Governance
Table 20: Goldman Sachs Private Wealth Management: Financial Deals
Table 21: Goldman Sachs Private Wealth Management: Financial Performance
Table 22: Goldman Sachs Private Wealth Management: Regulatory and Legal Events
Table 23: Goldman Sachs Private Wealth Management: Strategy and Operations

List of Figures
Figure 1: Goldman Sachs Private Wealth Management: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Goldman Sachs Private Wealth Management: M&A Activity by Geography (TTM*)
Figure 3: Goldman Sachs Private Wealth Management: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: Goldman Sachs Private Wealth Management: M&A Average Deal Size - Value (US$m)
Figure 5: Goldman Sachs Private Wealth Management: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: Goldman Sachs Private Wealth Management: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: Goldman Sachs Private Wealth Management: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: Goldman Sachs Private Wealth Management: Corporate Venturing by Geography (2015 - YTD*2019)

★海外企業調査レポート[Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • J & J Snack Foods Corp:企業の戦略・SWOT・財務情報
    J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report Summary J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Connect Group PLC (CNCT):企業の財務・戦略的SWOT分析
    Connect Group PLC (CNCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務情報
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ITT Inc (ITT):企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • US Foods, Inc.:企業の戦略・SWOT・財務分析
    US Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary US Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • Kohlberg Kravis Roberts & Co LP:企業のM&A・事業提携・投資動向
    Kohlberg Kravis Roberts & Co LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kohlberg Kravis Roberts & Co LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析
    Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務分析
    Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NuVascular Technologies Inc:企業の製品パイプライン分析2018
    Summary NuVascular Technologies Inc (NuVascular Technologies) is a developer of medical devices for the treatment of patients suffering from end-stage renal diseases. The company offers hemodialysis access grafts, arteriovenous suture, central venous catheter cuffs, drug-eluting vessel wrap, drug-el …
  • Andritz AG (ANDR):企業の財務・戦略的SWOT分析
    Andritz AG (ANDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CanBas Co Ltd (4575):製薬・医療:M&Aディール及び事業提携情報
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that develops therapeutics for cancer. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It provides two clinical oncology programs, CBP501 and CBS9106 with mutually …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • Hansen Technologies Ltd (HSN):企業の財務・戦略的SWOT分析
    Summary Hansen Technologies Ltd (Hansen Technologies) is a technology company that offers customer care, billing, and meter data management software solutions. The company provides outsourcing services such as facilities management, support center, consulting, host management, business continuity, i …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company offers chemical products such as intermediates, monomers and petrochemicals. Its performance pro …
  • CRH Plc (CRH):企業の財務・戦略的SWOT分析
    CRH Plc (CRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆